The consolidated entity will leverage AI and precision engineering to create a comprehensive ecosystem advancing drug delivery, home monitoring, and clinical intelligence. ROCHESTER, Minn., Jan. 9, 2026 /PRNewswire/ — Nanodropper, the leader in micro-volume ophthalmic delivery, today announced that Bedo Solutions and Viseon Labs have agreed on terms to join its precision eyecare platform under a… Continue reading Nanodropper® Now Operating as Mu Medical™, Planned Expansion of Precision Eyecare Platform with Bedo Solutions and Viseon Labs
Tag: Morgan
Nanodropper® Now Operating as Mu Medical™, Planned Expansion of Precision Eyecare Platform with Bedo Solutions and Viseon Labs
The consolidated entity will leverage AI and precision engineering to create a comprehensive ecosystem advancing drug delivery, home monitoring, and clinical intelligence. ROCHESTER, Minn., Jan. 9, 2026 /PRNewswire/ — Nanodropper, the leader in micro-volume ophthalmic delivery, today announced that Bedo Solutions and Viseon Labs have agreed on terms to join its precision eyecare platform under a… Continue reading Nanodropper® Now Operating as Mu Medical™, Planned Expansion of Precision Eyecare Platform with Bedo Solutions and Viseon Labs
iOnctura CEO to present at the 2026 J.P. Morgan Healthcare Conference
Participation underscores growing excitement around company’s momentum and potential in precision oncology GENEVA, AMSTERDAM and CAMBRIDGE, Mass., Jan. 9, 2026 /PRNewswire/ — iOnctura, a clinical-stage biopharmaceutical company developing precision oral small molecules for neglected and hard-to-treat cancers, today announces that its Chief Executive Officer, Catherine Pickering, will present at the 44th Annual J.P. Morgan Healthcare… Continue reading iOnctura CEO to present at the 2026 J.P. Morgan Healthcare Conference
Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
— BRINSUPRI® (brensocatib) Unaudited Total Revenues of Approximately $144.6 Million for First Full Quarter of Launch; Approximately $172.7 Million for Full-Year 2025— —ARIKAYCE® (amikacin liposome inhalation suspension) Exceeds the Upper End of Guidance Range for Full-Year 2025 with Unaudited Global Revenues of Approximately $433.8 Million— —Full-Year 2026 Global ARIKAYCE Revenues Expected to be Between $450 Million and $470 Million— —Topline Data from Phase… Continue reading Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
Two Decades of Brand Evolution: Global Top Brands Witness Transformation and Perseverance of Consumer Electronics Industry
LAS VEGAS, Jan. 9, 2026 /PRNewswire/ — The Global Top Brands Award Ceremony and International Consumer Electronics Industry Leaders’ Summit were held in Las Vegas on January 7, 2026 during the Consumer Electronics Show (CES), a major event in the global consumer electronics industry. This event marked the 20th anniversary of the Global Top Brands… Continue reading Two Decades of Brand Evolution: Global Top Brands Witness Transformation and Perseverance of Consumer Electronics Industry
Innovent’s Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration
SAN FRANCISCO and SUZHOU, China, Jan. 8, 2026 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, today announced that the company’s partner Ollin reported positive topline results from its randomized,… Continue reading Innovent’s Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
SAN RAFAEL, Calif., Jan. 8, 2026 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will present at the 44th Annual J.P. Morgan Conference on Monday, January 12, 2026, at 11:15 am PT / 2:15 pm ET, in San Francisco, California. The Company plans to… Continue reading BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
BillingPlatform Appoints Industry Veteran Chris Bishop as CEO to Drive Next Phase of Growth
Former Conga executive takes over for Dennis Wall who will remain on BillingPlatform’s Board of Directors DENVER, Jan. 8, 2026 /PRNewswire/ — BillingPlatform, the leader in enterprise monetization, today announced Chris Bishop as the company’s new CEO. Bishop succeeds Dennis Wall, who will remain engaged with the company as a member of its Board of Directors.… Continue reading BillingPlatform Appoints Industry Veteran Chris Bishop as CEO to Drive Next Phase of Growth
Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
ALPHARETTA, Ga., Jan. 7, 2026 /PRNewswire/ — Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Tuesday, Jan. 13, at approximately 2:15 p.m. PST. A webcast of the conference presentation will be available on the Investors section of the Avanos… Continue reading Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
PALO ALTO, Calif., Jan. 7, 2026 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today that senior management will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 12, 2026, at 1:30 p.m. Pacific Time. A live webcast of the presentation will be… Continue reading Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference